spiperone has been researched along with pirenzepine in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (50.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dannals, RF; Frost, JJ; Ravert, HT; Wagner, HN; Wilson, AA | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Barrantes, MA; Blosser, JC; Manian, AA; McCreedy, SA; Palmer, GC | 1 |
Joyce, JN | 1 |
4 other study(ies) available for spiperone and pirenzepine
Article | Year |
---|---|
Synthesis and biological evaluation of [125I]- and [123I]-4-iododexetimide, a potent muscarinic cholinergic receptor antagonist.
Topics: Animals; Dexetimide; Iodine Radioisotopes; Isotope Labeling; Male; Mice; Parasympatholytics; Piperidines; Receptors, Muscarinic; Tomography, Emission-Computed | 1989 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Correlation of activity of chlorpromazine and respective hydroxy, dimethoxy and sulphoxide analogues on dopamine, muscarinic, histamine and calmodulin sites of action.
Topics: Adenylyl Cyclase Inhibitors; Animals; Binding Sites; Calmodulin; Cerebral Cortex; Chlorpromazine; Cyclic AMP; Dopamine; Histamine; Hypothalamus; Phosphoric Diester Hydrolases; Pirenzepine; Rats; Receptors, Dopamine; Receptors, Muscarinic; Spiperone; Sulfoxides | 1988 |
Differential response of striatal dopamine and muscarinic cholinergic receptor subtypes to the loss of dopamine. III. Results in Parkinson's disease cases.
Topics: Aged; Aged, 80 and over; Autoradiography; Benzazepines; Dopamine; Female; Humans; Male; Mazindol; Middle Aged; Parasympatholytics; Parkinson Disease; Pirenzepine; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Muscarinic; Spiperone; Tritium | 1993 |